Valirx Share Discussion Threads

[tburns] 06/9/2020 06:58

He did the Same on SYME too!

[jasonpugh] 06/9/2020 05:28

As much as I’d like to believe the Goldman note is genuine.. it appears that it’s not...
Would love to be wrong however

[nico115] 06/9/2020 00:04

Goldman's have huge sway in the city The American peers are valued at 100x Val The US could push this into triple figures Tuesday on the back of this buy note

[jasonpugh] 05/9/2020 19:31

Thanks for info.

[jasonpugh] 05/9/2020 18:43

This broker opinion will shoot valirx through the roof on Monday if authentic

[nico115] 05/9/2020 17:05

Wow Goldman's rate Val as their top tip of 2020!! Fantastic !!

[412069] 05/9/2020 14:47

A brilliant post from lse BB.


People may have already guessed, but I’m particularly excited about 201. It has many different possible applications too, being in the family of tyrosine kinase (Src) inhibitors (more on this later...sorry, I’m in a particularly boring mood today, being stuck in the house) which have long been known to be successful in inhibiting the growth of tumours. This is why we can look into the possibilities of it being successful for endometriosis and breast cancer, inflammation responses and other things, as the pathways can be similar. 401 (sorry Valju!) I could take or leave.

I’m expecting much better results than DDDD (before anyone makes a note of me mentioning them again, sorry but it is relevant, although I do think they will be incredibly successful in other areas of their research, especially ibs) because their treatment for prostate cancer isn’t targeted enough. It produces a more general immune response, which is great and is why it needs to be used alongside another immunotherapy such as Keytruda (which only has about 40 ish percent success rate itself...) but 201 has the potential to achieve much better results in this particular scenario. This is because it’s the first use of a drug that actively targets the interaction of androgen receptors with the src protein. Src proteins drive tumour proliferation, there are other successful drugs That are on the market that effectively prevent tumour development in this way (Dasatinib and masitinib, for example). Both of these drugs are also being evaluated for potential other uses, as the Src protein is responsible for lots of things, which is why I’m excited about other possible uses for Val 201.
Dasatinib was actually trialled as a potential prostate cancer drug and eventually wasn’t successful enough. It completed three phases and the results from it’s phase two were seemingly worse than ours point to already. Their disease lack of progression was 43% after 12 weeks and 19% after 24 weeks. They progressed to a phase three from this. It is however a drug of choice and extremely successful at treating leukaemia and had an incredibly high success rate (huge market and does extremely well). Our drug would appear to be much better for prostate cancer because it targets the androgen interaction with the Src protein and inhibits the entire process, along with inhibiting the Src protein...whereas Dasatinib only targeted the Src protein to inhibit it.

All my own opinion obviously, but based on the increasing amount of research conducted to date

[riz000] 04/9/2020 15:33

“X KING OF TAJ MAHAL” 👑

I think we close at 26p with a possible rns next week I think we get some decent buying this afternoon as we have had it all week

[riz000] 04/9/2020 15:31

“X KING OF TAJ MAHAL” 👑

Come on VAL do another SNG here

[tburns] 04/9/2020 14:41

Only if they dont want to take advantage of a min rise to 40p when 201 news comes during this month. The huge volume of 50k and 100k buys earlier this week speaks volumes for institutions taking positions here I reckon Chesty.

[shares188] 04/9/2020 14:40

I'm liking this, could easily be back to £1
But my charts are saying with good news
£3 easily achievable.

[chesty1] 04/9/2020 14:27

Will the hot money move out into the weekend?

[ball deap] 04/9/2020 11:21

NYCT is a great example, currently on a 16 bagger... from lows.

[guss] 04/9/2020 11:14

That just value equivalent, I.e. there have been at least two 1:125 share consolidations that should have raised the price but, as usual, after a consolidation the price just falls away again and value is lost.

[uknighted] 04/9/2020 10:39

I’ve been in thIs pre RTO and if this was ever £12 a share I would have been long gone!!

[nico115] 04/9/2020 10:02

You have much more chance making money now cos this mgmnt get paid 30k each and old mgmnt got paid 150k each !!BOD costs 300k not 900kThat's a good starting point and why I bought a stake here at 6p

[guss] 04/9/2020 10:00

Look at the historic chart.
There have been a couple of share consolidations, 1 for every 125 in May 15 and again this year.

TBH I just looked at the chart,not bothering to work it out but sounds about right.
I’ve been underwater and averaged down many times over many years. Only ever been in the black once. Fingers crossed it might happen again...soon.

[uknighted] 04/9/2020 09:40

GUSS I don’t think that is correct. How do you arrive at £12?

[guss] 04/9/2020 09:32

Just for perspective VAL was equivalent of £12 a share 5 years ago.

I wish I wish I wish.

[joeblogg2] 04/9/2020 09:16

14m market cap for a potential treatment for prostate cancer!!!

[hodhasharon] 04/9/2020 09:10

I value VAL at circa 50M (about 100p per share).